GRISEOFULVIN MICROSIZE
- Product NDC
- 23155-865
- 11-digit product format
- 231550865
- Labeler code
- 23155
- Product ID
- 23155-865_d6360b00-96f1-4508-82e8-8425f8393851
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- griseofulvin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
- Application
- ANDA060569
- Marketing category
- ANDA
- Marketing start
- 2023-06-30
- Substance
- GRISEOFULVIN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GRISEOFULVIN MICROSIZE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GRISEOFULVIN | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 32HRV3E3D5 |
| Rxcui | 310600 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 23155-865-01 | GRISEOFULVIN MICROSIZE | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 23155-865 | GRISEOFULVIN MICROSIZE (GRISEOFULVIN) TABLET [HERITAGE PHARMACEUTICALS INC D/B/A AVET PHARMACEUTICALS INC] | 1 | Current NDC, 1 package rows | 20230912_1c26d7a6-17d9-4a95-a4ee-cfc5fe6bb95d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 23155-865-01 | 23155086501 | 100 TABLET in 1 BOTTLE, PLASTIC (23155-865-01) | 100 tablet | 2023-06-30 | No | No | Current |